Director, CVRM Evidence StrategyAstraZeneca, Sweden
Disclosure information not submitted.
Comparative Analysis of High Dimensional Propensity Scoring and Dimensionality Reduction in Cohort Studies
Tuesday, August 27, 20248:15 AM – 8:30 AM CEST